title: Vascular injury during elevated glucose can be mitigated by erythropoietin and Wnt signaling.
abstract: Impacting a significant portion of the world's population with increasing incidence in minorities, the young, and the physically active, diabetes mellitus (DM) and its complications affect approximately 20 million individuals in the United States and over 100 million individuals worldwide. In particular, vascular disease from DM may lead to some of the most serious complications that can extend into both the cardiac and nervous systems. Unique strategies that can prevent endothelial cell (EC) demise and elucidate novel cellular mechanisms for vascular cytoprotection become vital for the prevention and treatment of vascular DM complications. Here, we demonstrate that erythropoietin (EPO), an agent that has recently been shown to extend cell viability in a number of systems extending beyond hematopoietic cells, prevents EC injury and apoptotic nuclear DNA degradation during elevated glucose exposure. More importantly, EPO employs Wnt1, a cysteine-rich glycosylated protein involved in gene expression, cell differentiation, and cell apoptosis, to confer EC cytoprotection and maintains the integrity of Wnt1 expression during elevated glucose exposure. In addition, application of anti-Wnt1 neutralizing antibody abrogates the protective capacity of both EPO and Wnt1, illustrating that Wnt1 is an important component in the cytoprotection of ECs during elevated glucose exposure. Intimately linked to this cytoprotection is the downstream Wnt1 pathway of glycogen synthase kinase (GSK-3beta) that requires phosphorylation of GSK-3beta and inhibition of its activity by EPO. Interestingly, inhibition of GSK-3beta activity during elevated glucose leads to enhanced EC survival, but does not synergistically improve protection by EPO or Wnt1, suggesting that EPO and Wnt1 are closely tied to the blockade of GSK-3beta activity. Our work exemplifies an exciting potential application for EPO in regards to the treatment of DM vascular disease complications and highlights a previously unrecognized role for Wnt1 and the modulation of the downstream pathway of GSK-3beta to promote vascular cell viability during DM.
authors: Division of Cellular and Molecular Cerebral Ischemia, Wayne State University School of Medicine, Detroit, Michigan 48201, USA.
authors: Zhao Zhong
authors: ZZ
authors: Chong
authors: Yan Chen
authors: YC
authors: Shang
authors: Kenneth
authors: K
authors: Maiese
mesh_terms: D000818:Animals; D000906:Antibodies / Q000494:pharmacology; D001921:Brain / Q000166:cytology; D002470:Cell Survival / Q000187:drug effects; D053938:DNA Fragmentation / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D042783:Endothelial Cells / Q000187:drug effects*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D004921:Erythropoietin / Q000494:pharmacology*; D005947:Glucose / Q000494:pharmacology*; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D015398:Signal Transduction / Q000187:drug effects*; D051155:Wnt1 Protein / Q000276:immunology / Q000378:metabolism* / Q000494:pharmacology
chemical_list: D000906:Antibodies; D004791:Enzyme Inhibitors; D051155:Wnt1 Protein; D004921:Erythropoietin; D005947:Glucose
references: Cancer Res. 2004 May 15;64(10):3474-8
references: 15150100
references: J Am Coll Cardiol. 2004 Jul 7;44(1):63-7
references: 15234408
references: Circulation. 2004 Aug 24;110(8):1006-12
references: 15302785
references: Am J Hum Genet. 2004 Nov;75(5):832-43
references: 15386214
references: Proc Natl Acad Sci U S A. 1996 Sep 17;93(19):10228-33
references: 8816781
references: Eur J Endocrinol. 1998 Oct;139(4):367-70
references: 9820611
references: Diabetologia. 2004 Oct;47(10):1695-703
references: 15502930
references: Neurology. 2004 Nov 23;63(10):1902-7
references: 15557509
references: Neurosignals. 2004 Nov-Dec;13(6):265-89
references: 15627815
references: JAMA. 2005 Jan 5;293(1):90-5
references: 15632341
references: Cell. 2005 Jan 14;120(1):137-49
references: 15652488
references: Diabetes. 2005 Feb;54(2):554-62
references: 15677515
references: Trends Pharmacol Sci. 2004 Nov;25(11):577-83
references: 15491780
references: Kidney Int. 1990 Nov;38(5):969-75
references: 2266682
references: J Cell Sci. 1992 Sep;103 ( Pt 1):23-37
references: 1429907
references: Diabet Med. 1994 Jun;11(5):475-9
references: 8088126
references: Arch Intern Med. 2005 Feb 28;165(4):466-9
references: 15738380
references: J Mol Neurosci. 2005;25(2):183-9
references: 15784966
references: Oncogene. 2005 Apr 21;24(18):3054-8
references: 15735684
references: J Am Coll Cardiol. 2005 May 3;45(9):1406-12
references: 15862410
references: Prog Neurobiol. 2005 Feb;75(3):207-46
references: 15882775
references: Brain Res Brain Res Rev. 2005 Jul;49(1):1-21
references: 15960984
references: Curr Neurovasc Res. 2005 Jan;2(1):55-72
references: 16181100
references: Curr Neurovasc Res. 2005 Oct;2(4):331-40
references: 16181124
references: Cancer Res. 2005 Oct 1;65(19):8604-7
references: 16204024
references: Histol Histopathol. 2006 Jan;21(1):103-24
references: 16267791
references: Curr Neurovasc Res. 2005 Dec;2(5):387-99
references: 16375720
references: Curr Neurovasc Res. 2005 Dec;2(5):425-46
references: 16375723
references: Ann Hematol. 2006 Feb;85(2):79-85
references: 16132904
references: J Pharmacol Exp Ther. 2006 Mar;316(3):999-1005
references: 16306273
references: Nat Genet. 2006 Mar;38(3):320-3
references: 16415884
references: J Clin Invest. 2006 Mar;116(3):683-94
references: 16511603
references: Lancet. 2006 Mar 11;367(9513):847-58
references: 16530579
references: Curr Med Chem. 2006;13(8):883-95
references: 16611073
references: Free Radic Biol Med. 2006 May 15;40(10):1776-84
references: 16678015
references: Circ Res. 2006 Jun 9;98(11):1405-13
references: 16645141
references: Cell Mol Life Sci. 2006 Jun;63(11):1226-35
references: 16568235
references: Metabolism. 2006 Aug;55(8):1046-52
references: 16839840
references: Int Urol Nephrol. 2006;38(2):295-310
references: 16868702
references: Diabet Med. 2006 Aug;23(8):839-44
references: 16911620
references: Curr Neurovasc Res. 2006 Aug;3(3):187-201
references: 16918383
references: Brain Res. 2006 Sep 7;1108(1):179-87
references: 16872585
references: Pediatrics. 2006 Sep;118(3):e635-40
references: 16908620
references: Diabetes. 2006 Oct;55(10):2863-70
references: 17003354
references: J Am Soc Nephrol. 2006 Oct;17(10):2812-20
references: 16943306
references: J Med Genet. 2006 Oct;43(10):798-803
references: 16723389
references: Acta Pharmacol Sin. 2006 Nov;27(11):1389-94
references: 17049112
references: Am J Physiol Heart Circ Physiol. 2006 Dec;291(6):H2660-8
references: 16951046
references: BMC Genomics. 2006;7:301
references: 17134498
references: Int J Mol Med. 2007 Feb;19(2):263-72
references: 17203200
references: Cell Signal. 2007 Mar;19(3):634-45
references: 17045782
references: Epilepsia. 2007 Jan;48(1):175-81
references: 17241225
references: Diabetes. 2007 Feb;56(2):295-303
references: 17259372
references: Neuron. 2007 Feb 1;53(3):387-97
references: 17270735
references: Curr Neurovasc Res. 2007 Feb;4(1):63-71
references: 17311546
references: Mediators Inflamm. 2006;2006(5):18061
references: 17392570
references: Br J Pharmacol. 2007 Apr;150(7):839-50
references: 17339844
references: Brain Dev. 2007 Jun;29(5):273-80
references: 17071037
references: J Neurochem. 2007 Apr;101(2):342-54
references: 17402968
references: J Biol Chem. 2007 Apr 20;282(16):12030-7
references: 17242403
references: Cell Signal. 2007 Jun;19(6):1150-62
references: 17289346
references: Curr Med Chem. 2007;14(16):1729-38
references: 17627510
references: J Neurosci Res. 2000 Jul 1;61(1):21-32
references: 10861796
references: JAMA. 2000 Dec 27;284(24):3157-9
references: 11135780
references: J Intern Med. 2001 Mar;249(3):225-35
references: 11285042
references: Nurs Clin North Am. 2001 Jun;36(2):175-92, v
references: 11382558
references: Diabetes Res Clin Pract. 2002 May;56(2):115-23
references: 11891019
references: Oncogene. 2002 Sep 26;21(43):6598-605
references: 12242657
references: Circulation. 2002 Dec 3;106(23):2973-9
references: 12460881
references: Nephrol Dial Transplant. 2003 Jan;18(1):141-6
references: 12480972
references: J Cereb Blood Flow Metab. 2003 Mar;23(3):320-30
references: 12621307
references: Br J Pharmacol. 2003 Mar;138(6):1107-18
references: 12684267
references: JAMA. 2004 Jan 21;291(3):335-42
references: 14734596
references: Arch Intern Med. 2004 Feb 9;164(3):262-76
references: 14769622
references: Histol Histopathol. 2004 Apr;19(2):495-504
references: 15024710
references: Diabetes Care. 2004 May;27(5):1028-32
references: 15111515